<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table4" position="float"><object-id pub-id-type="doi">10.7554/eLife.26693.010</object-id><label>Table 4.</label><caption><title>7-day antiproliferative activities of MELK inhibitors in a panel of breast cancer cell lines*.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th colspan="6" valign="top">7-day antiproliferative IC<sub>50</sub> (&#956;M)</th></tr><tr><th valign="top"/><th colspan="4" valign="top">Basal-like</th><th colspan="2" valign="top">Luminal</th></tr></thead><tbody><tr><td valign="top">Cell line</td><td valign="top">MDA-MB-468</td><td valign="top">MDA-MB-468 <break/>(second source)</td><td valign="top">BT-549</td><td valign="top">HCC70</td><td valign="top">MCF7</td><td valign="top">T-47D</td></tr><tr><td valign="bottom">HTH-01-091</td><td valign="bottom">2.71</td><td valign="bottom">10.7</td><td valign="bottom">2.82</td><td valign="bottom">2.43</td><td valign="bottom">4.13</td><td valign="bottom">0.78</td></tr><tr><td valign="bottom">OTSSP167</td><td valign="bottom">0.012</td><td valign="bottom">0.033</td><td valign="bottom">0.009</td><td valign="bottom">0.021</td><td valign="bottom">0.027</td><td valign="bottom">0.009</td></tr><tr><td valign="bottom">MRT199665</td><td valign="bottom">0.16</td><td valign="bottom">0.91</td><td valign="bottom">0.31</td><td valign="bottom">0.075</td><td valign="bottom">0.11</td><td valign="bottom">0.62</td></tr><tr><td valign="bottom">NVS-MELK8a</td><td valign="bottom">2.96</td><td valign="bottom">8.4</td><td valign="bottom">4.98</td><td valign="bottom">4.17</td><td valign="bottom">2.81</td><td valign="bottom">4.90</td></tr></tbody></table><table-wrap-foot><fn><p>*IC<sub>50</sub> values were estimated based on &#8216;log(inhibitor) vs. normalized response -- Variable slope&#8217; using GraphPad Prism 7. Experiments were performed in duplicates.</p></fn></table-wrap-foot></table-wrap>